ChartRow logo
CAI
$31.11+1.30%
as of close, Oct 20, 2026
☾ AH $31.11 +1.30%
Share this page

CAI — Caris Life Sciences Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0

Key stats#

Price data

Price
$31.11
YTD price return
+15.31%
YTD total return
+15.31%
Next earnings
Nov 4, 2026 · After close
Market cap
8.8B
Enterprise value
8.3B
Shares outstanding
282.6M
52W low
$14.19
52W high
$33.13
From 52W high
-6.10%
From 52W low
+119.24%
52W range
89%

Volume

Rel volume
0.76×
30D volume
4.6M
30D $ vol
136.7M

Fundamentals

Sales (ttm)
989.6M
Sales/share
$3.50
EPS (ttm)
$0.37
FCF (ttm)
124M
FCF/share
$0.44
Book value/share
$2.09
Net margin
10.62%
ROE
17.77%
ROA
8.55%
Debt / equity
0.66×
Current ratio
5.53

Growth (CAGR, ttm) · 10Y

Sales
+85.45%+59.98%n/an/a
Shares
+0.49%n/an/an/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share
+84.55%n/an/an/a
Book value/share
+30.04%n/an/an/a
Price
-1.24%n/an/an/a
Total return
-1.24%n/an/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
84.8×
Fwd P/E
82.2×
P/S (ttm)
8.9×
P/B (mrq)
14.9×
P/FCF (ttm)
70.9×
EV/EBITDA (fy)
47.8×
EV/Sales (ttm)
8.4×
FCF yield (ttm)
1.41%
Buyback yield (realized, 1y)
-0.49%
Shareholder yield (realized, 1y)
-0.49%
Buyback yield (cash, ttm)
0.24%
Shareholder yield (cash, ttm)
0.24%

Performance · price return · as of 2026-10-20#

1D
+1.30%
5D
+5.35%
1M
+3.77%
3M
+99.94%
YTD
+15.31%
1Y
-1.24%
5Y
—

Financial statements

Open full CAI financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company+11.34%+3.49%
JNJJohnson & Johnson-3.94%+2.19%
ABBVAbbVie Inc.+9.52%+2.26%
UNHUnitedHealth Group Incorporated Common Stock (DE)+11.24%+3.04%
MRKMerck & Co. Inc.+0.97%+3.25%
NVSNovartis AG+9.45%+2.29%
TMOThermo Fisher Scientific Inc.+5.51%+1.18%
AMGNAmgen Inc.+13.82%+3.29%